RNA delivery is the transport of RNA molecules such as mRNA, siRNA, miRNA, antisense oligonucleotides, or guide RNAs into cells so they can express, silence, regulate, or edit biological information. Because RNA is fragile, charged, and easily degraded, RNA delivery depends on carriers that protect cargo, promote uptake, support endosomal escape, and reach target tissues. Lipid nanoparticles, polymeric nanoparticles, conjugates, extracellular vesicles, and hybrid nanocarriers are widely studied.
RNA delivery matters because RNA therapeutics have become a major platform for vaccines, gene silencing, protein replacement, cancer immunotherapy, rare diseases, and genome editing. The success of mRNA vaccines highlighted the importance of delivery chemistry, formulation, and manufacturing. Key challenges include tissue specificity, immune activation, dosing, stability, repeat administration, safety, and scalable production. The field connects closely to lipid nanoparticles, gene delivery, and nanovaccines.
Conferences on RNA delivery appear in biotechnology, nanomedicine, pharmaceutical science, vaccine development, gene therapy, and drug-delivery programs. Sessions often cover lipid nanoparticles, extrahepatic targeting, mRNA platforms, siRNA therapeutics, formulation, safety, and clinical translation. Tracking RNA-delivery events helps researchers follow a rapidly advancing area where nanoscale delivery systems enable new classes of medicine.